Microtia Clinical Trial
Official title:
Modulation of the Intestinal Microbiome, and Its Effects on Endurance Exercise Capacity in Moderately Trained Individuals
The aim of this study is to investigate the effect of a six-week period personalised food intervention with prebiotic supplementation on intense exercise performance in healthy, recreationally active adults.
Status | Recruiting |
Enrollment | 34 |
Est. completion date | September 30, 2021 |
Est. primary completion date | August 23, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 40 Years |
Eligibility | Inclusion Criteria: - Male or female 18 - 40 y - BMI range 18.5 - 25 kg/m2 - Recreational active (performing non-competitive physical endurance exercise at least two times per week with a minimum duration of 60 minutes per exercise bout) Exclusion Criteria: - Smoking - Performing regular resistance training (3+ times per week, carrying out progressive overload training) - Subject following an overly imbalanced or restrictive diet as per nutritional advice - Participants who received antibiotics in the 90 days prior to the start of the study - Self-admitted lactose intolerance - Administration of probiotic or prebiotic supplements in the 14 days prior to the study |
Country | Name | City | State |
---|---|---|---|
Netherlands | Maastricht University | Maastricht | Limburg |
Lead Sponsor | Collaborator |
---|---|
Maastricht University |
Netherlands,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Time to Exhaustion | Time on cycle ergometer until exhaustion | From baseline to end of the study (up to max 45 days) | |
Secondary | Gut microbiota composition | Composition of the gut microbiota by faecal sample analysis | From baseline to end of the study (up to max 45 days) | |
Secondary | Plasma short chain fatty acids | Short chain fatty acids in plasma | From baseline to end of the study (up to max 45 days) | |
Secondary | Blood glucose | Fasted blood glucose | From baseline to end of the study (up to max 45 days) | |
Secondary | Insulin | Fasted insulin | From baseline to end of the study (up to max 45 days) | |
Secondary | Intestinal permeability by sugar test | Intestinal permeability measured by a sugar drink test | From baseline to end of the study (up to max 45 days) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05288790 -
Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
|
Phase 2 | |
Recruiting |
NCT05963659 -
Nitrate Modulates Cognitive Impairment Via Oral Microbiota.
|
N/A | |
Completed |
NCT04130321 -
Demonstration of the Prebiotic-like Effects of Camu-camu Consumption Against Obesity-related Disorders in Humans
|
N/A | |
Recruiting |
NCT05929976 -
InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort
|
||
Withdrawn |
NCT04230746 -
Effect of Antibiotics on Urinary Microbiome
|
Early Phase 1 | |
Active, not recruiting |
NCT06289283 -
Microbiota in Urine and Urothelium Can be a Factor for Induction of Urinary Bladder Cancer. The Study Will Examine Urine and Bladder Cancer Tissues From Male Patients and Urine of Controls Using Whole Genomic Sequencing Techniques and 16S rRNA. The Aim is to Elucidate Role of Microbiota in Bladder
|
||
Recruiting |
NCT05714566 -
Research on Gut Microbiome and Metabolomics Alterations in C.Difficile Infected IBD Patients
|
||
Enrolling by invitation |
NCT06225336 -
Subcutaneous Implant Combination Product (AUR-201) in Patients With Unilateral Microtia (Australia)
|
Phase 1 | |
Recruiting |
NCT05068362 -
Auricular Reconstruction in Microtia by Medpor Implant Following Tissue Expansion
|
N/A | |
Completed |
NCT02224677 -
Craniofacial Microsomia: Longitudinal Outcomes in Children Pre-Kindergarten (CLOCK)
|
||
Not yet recruiting |
NCT05615116 -
Clinical Study on the Distribution of Digestive Tract Microbiota Before and After Ileocecal Resection in Crohn's Disease
|
||
Enrolling by invitation |
NCT06220994 -
the Gut Microbiome and Metabolomics in Chronic Lower extreMities Threatening Ischemia
|
||
Completed |
NCT00958802 -
Tissue Engineering Microtia Auricular Reconstruction: in Vitro and in Vivo Studies
|
Phase 0 | |
Recruiting |
NCT06087874 -
Preventive Effect of Perinatal Oral Probiotic Supplementation (POPS) on Neonatal Jaundice
|
Phase 2 | |
Suspended |
NCT03624608 -
Evaluation of the Auryzon Devices in the Optimization of Ear and Nose Reconstruction Procedures
|
N/A | |
Not yet recruiting |
NCT06394687 -
The Digestion of Protein Powders in Healthy Participants Using SIMBA and LIMBA Capsule
|
N/A | |
Completed |
NCT05417360 -
Akkermansia and Weight Maintenance
|
N/A | |
Recruiting |
NCT02518035 -
Silicone Gel to Improve Scar in Microtia Patients
|
Phase 4 | |
Recruiting |
NCT06078566 -
Long-Term Follow-Up Study of Unilateral Microtia Patients Implanted With AUR-201
|
Phase 1/Phase 2 | |
Recruiting |
NCT06072040 -
Subcutaneous Implant Combination Product (AUR-201) in Patients With Unilateral Microtia
|
Phase 1/Phase 2 |